1. Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanoma. Issue 2 (April 2016) Authors: Schreuer, Max; Meersseman, Geert; van Den Herrewegen, Sari; Jansen, Yanina; Seremet, Teofila; Bott, Ambre; Chevolet, Ines; Wilgenhof, Sofie; Maertens, Geert; Neyns, Bart Journal: Melanoma research Issue: Volume 26:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial. Issue 4 (April 2017) Authors: Schreuer, Max; Jansen, Yanina; Planken, Simon; Chevolet, Ines; Seremet, Teofila; Kruse, Vibeke; Neyns, Bart Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy. Issue 1 (February 2018) Authors: Seremet, Teofila; Planken, Simon; Schreuer, Max; Jansen, Yanina; Delaunoy, Mélanie; El Housni, Hakim; Lienard, Danielle; Del Marmol, Véronique; Heimann, Pierre; Neyns, Bart Journal: Melanoma research Issue: Volume 28:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients. Issue 1 (December 2016) Authors: Seremet, Teofila; Koch, Alexander; Jansen, Yanina; Schreuer, Max; Wilgenhof, Sofie; Marmol, Véronique; Liènard, Danielle; Thielemans, Kris; Schats, Kelly; Kockx, Mark; Criekinge, Wim; Coulie, Pierre; Meyer, Tim; Baren, Nicolas; Neyns, Bart Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors. Issue 1 (December 2016) Authors: Schreuer, Max; Meersseman, Geert; Van Den Herrewegen, Sari; Jansen, Yanina; Chevolet, Ines; Bott, Ambre; Wilgenhof, Sofie; Seremet, Teofila; Jacobs, Bart; Buyl, Ronald; Maertens, Geert; Neyns, Bart Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Severe treatment-induced inflammatory polyarthritis in advanced melanoma patients: 2 case reports. Issue 3 (29th March 2022) Authors: Lauwyck, Justine; Schreuer, Max; Meric de Bellefon, Laurent; Van Erps, Joanna; Neyns, Bart; Aspeslagh, Sandrine Journal: Melanoma research Issue: Volume 32:Issue 3(2022) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanoma. Issue 2 (April 2015) Authors: Seremet, Teofila; Lienard, Danielle; Suppa, Mariano; Trepant, Anne-Laure; Rorive, Sandrine; Woff, Erwin; Cuylits, Nicolas; Jansen, Yanina; Schreuer, Max; del Marmol, Véronique; Neyns, Bart Journal: Melanoma research Issue: Volume 25:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients. Issue 4 (August 2015) Authors: Chevolet, Ines; Schreuer, Max; Speeckaert, Reinhart; Neyns, Bart; Hoorens, Isabelle; van Geel, Nanja; Krüse, Vibeke; Hennart, Benjamin; Allorge, Delphine; Van Gele, Mireille; Brochez, Lieve Journal: Melanoma research Issue: Volume 25:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?. Issue 4 (August 2015) Authors: Chevolet, Ines; Schreuer, Max; Speeckaert, Reinhart; Neyns, Bart; Hoorens, Isabelle; van Geel, Nanja; Krüse, Vibeke; Hennart, Benjamin; Allorge, Delphine; Van Gele, Mireille; Brochez, Lieve Journal: Melanoma research Issue: Volume 25:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗